• News
  • SAN DIEGO
  • Health

Quidel's strep assay receives FDA 510(k) clearance

San Diego-based Quidel Corp. (Nasdaq: QDEL) received 510(k) clearance from the Food and Drug Administration for the sale of its AmpliVue Group B Strep Assay.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!